JP2006500337A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500337A5
JP2006500337A5 JP2004525233A JP2004525233A JP2006500337A5 JP 2006500337 A5 JP2006500337 A5 JP 2006500337A5 JP 2004525233 A JP2004525233 A JP 2004525233A JP 2004525233 A JP2004525233 A JP 2004525233A JP 2006500337 A5 JP2006500337 A5 JP 2006500337A5
Authority
JP
Japan
Prior art keywords
benzazepine
phenylpropyl
ethoxycarbonyl
tetrahydro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004525233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500337A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/007771 external-priority patent/WO2004013105A1/en
Publication of JP2006500337A publication Critical patent/JP2006500337A/ja
Publication of JP2006500337A5 publication Critical patent/JP2006500337A5/ja
Withdrawn legal-status Critical Current

Links

JP2004525233A 2002-07-26 2003-07-17 塩酸ベナゼプリルの結晶多形形態および非晶質形態 Withdrawn JP2006500337A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02405653 2002-07-26
PCT/EP2003/007771 WO2004013105A1 (en) 2002-07-26 2003-07-17 Crystalline polymorphic and amorphous forms of benazepril hydrochloride

Publications (2)

Publication Number Publication Date
JP2006500337A JP2006500337A (ja) 2006-01-05
JP2006500337A5 true JP2006500337A5 (https=) 2006-08-31

Family

ID=31198001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004525233A Withdrawn JP2006500337A (ja) 2002-07-26 2003-07-17 塩酸ベナゼプリルの結晶多形形態および非晶質形態

Country Status (6)

Country Link
US (1) US20050107359A1 (https=)
EP (1) EP1525189A1 (https=)
JP (1) JP2006500337A (https=)
AU (1) AU2003250086A1 (https=)
CA (1) CA2492949A1 (https=)
WO (1) WO2004013105A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1711493A2 (en) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Crystalline forms of zolmitriptan
WO2006084761A1 (en) * 2005-02-11 2006-08-17 Albemarle Corporation Crystalline polymorphs of benazepril hydrochloride
EP1891014B1 (en) * 2005-05-12 2009-03-11 Lupin Ltd. Improved process for crystallization of benazepril hydrochloride
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
WO2014080259A1 (en) * 2012-11-21 2014-05-30 Enaltec Labs Pvt. Ltd. Novel polymorphic forms of alcaftadine
CN104788376A (zh) * 2014-01-17 2015-07-22 海门慧聚药业有限公司 一种盐酸贝那普利的新晶型及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072352B1 (de) * 1981-08-11 1986-03-05 Ciba-Geigy Ag Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
JP2004513112A (ja) * 2000-10-31 2004-04-30 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド フルバスタチンナトリウムの結晶形
PL361912A1 (en) * 2000-10-31 2004-10-04 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
EP1345903A1 (en) * 2000-12-21 2003-09-24 Ciba SC Holding AG Crystalline forms of cerivastatin sodium
WO2003013512A2 (en) * 2001-08-03 2003-02-20 Ciba Specialty Chemicals Holding Inc. Crystalline forms of fluvastatin sodium

Similar Documents

Publication Publication Date Title
US7612214B2 (en) Organic amine salts of glutamic acid derivatives and their application
JP5395901B2 (ja) R−β−アミノフェニル酪酸誘導体の調製方法
JP5319885B2 (ja) モナティンの製造方法
US6872853B1 (en) Polymorphic forms of sertraline hydrochloride
US20090221595A1 (en) Crystalline form of sitagliptin
US9227915B2 (en) Process for the preparation of a crystalline L-MGDA trialkali metal salt
JP5503546B2 (ja) 4,5−ジメトキシ−1−(メチルアミノメチル)−ベンゾシクロブタンの分離
TW200815344A (en) Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide
ME02750B (me) Kristalni oblik gama - d iv abradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže
JP2005509025A5 (https=)
JP2006518354A5 (https=)
JP2006500337A5 (https=)
PL160103B1 (pl) Sposób wytwarzania kwasu L-/-/-2-amino-3-/3,4-dwuhydroksyfenylo/propionowego PL PL PL PL PL
JP3872344B2 (ja) N−〔(s)−1−カルボキシブチル〕−(s)−アラニンエステルの新規合成方法及びペリンドプリルの合成における適用
WO2006109671A1 (ja) モルヒナン誘導体の結晶及びその製造法
JP3930322B2 (ja) N−〔(s)−1−カルボキシブチル〕−(s)−アラニンエステルの新規合成方法及びペリンドプリルの合成における適用
TWI325416B (en) Improved process for the production of nitroisourea derivative
TWI327138B (en) Improved process for the production of nitroguanidine derivative
US20090240064A1 (en) Crystalline form of atorvastatin hemi-calcium
JP2008526836A (ja) シブトラミンの無機酸塩
HU230148B1 (hu) Eljárás alkoxi-furanon-amin-származékok előállítására, az eljárással kapott vegyületek és a vegyületek alkalmazása
US6130331A (en) Chemical synthesis of a chiral 1,4-oxazin-2-one
AU6086599A (en) Method for producing (-)-alpha-(difluoromethyl)ornithine-monohydrochloride monohydrate
CN101228179B (zh) 制备培哚普利特丁胺的方法
US20050113309A1 (en) Crystalline forms(2s)-n-5[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2[(carboxymethyl) amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o